JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online June 15, 2007
J Nucl Med 2007, doi:10.2967/jnumed.107.039750
© 2007 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.107.039750v1
48/7/1122    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santana, C. A.
Right arrow Articles by Esteves, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santana, C. A.
Right arrow Articles by Esteves, F. P.


Quantitative 82Rb PET/CT: Development and Validation of Myocardial Perfusion Database

Cesar A. Santana 1*, Russell D. Folks 1, Ernest V. Garcia 1, Liudmila Verdes 1, Rupan Sanyal 1, Jon Hainer 2, Marcelo F. Di Carli 2, and Fabio P. Esteves 1

1 Emory University School of Medicine, Atlanta, Georgia
2 Brigham and Women's Hospital, Boston, Massachusetts

* To whom correspondence should be addressed. E-mail: csantan{at}emory.edu.


   Abstract

The use of myocardial perfusion 82Rb PET/CT studies continues to increase but its accuracy using database quantification methods for the diagnosis of coronary artery disease (CAD) has not been established. Methods: A sex-independent normal database and criteria for abnormality for rest-stress 82Rb PET/CT myocardial perfusion imaging were developed and validated by evaluation of 281 patients (136 females: mean age ± SD, 63.3 ± 13.3 y; 145 males: mean age ± SD, 63.9 ± 12.8 y) who underwent a rest-adenosine stress 82Rb PET/CT study. These patients were divided into 3 groups: (a) healthy group: 30 patients, with <5% likelihood of CAD (low likelihood [LLK]) based on sequential Bayesian analysis; these patients were used to generate the normal distribution; (b) pilot group: 174 patients; these patients were used to determine the optimal criteria for detecting and localizing the perfusion abnormality; and (c) validation group: 76 patients (23 with LLK of CAD and 53 who underwent coronary angiography; these patients were used for prospective validation. Results: Of the 53 patients who underwent coronary angiography, 8 had <50% stenosis and 45 patients had at least one stenosis ≥50% in one major artery. Fifteen patients had single-vessel disease, 17 had double-vessel disease, and 13 had triple-vessel disease. The prospective validation shows a normalcy rate of 78% (18/23) for global CAD. The analyses by individual arteries show a normalcy rate of 96% (22/23) for the left anterior descending coronary artery, 96% for the left circumflex coronary artery (22/23), and 100% for the right coronary artery (23/23). The overall sensitivity for detection of CAD (≥50% stenosis) was 93% (42/45). The overall specificity for detection of the absence of CAD (≤50% stenosis) was 75% (6/8). Also, the positive predictive value for global CAD was 95% (42/44), the negative predictive value was 67% (6/9), and the accuracy was 91% (48/53). Conclusion: The quantitative 82Rb PET/CT database created and validated in this study is highly accurate for the detection and localization of CAD. Physicians should consider using the quantitative output of these algorithms as decision support tools to aid with image interpretation.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
C M TONGE, R C FERNANDEZ, and M T HARBINSON
Current issues in nuclear cardiology
Br. J. Radiol., April 1, 2008; 81(964): 270 - 274.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.